Clinical Trial Update: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ticagrelor (AZD6140) to clopidogrel in Asian/Japanese patients with non-ST- and ST-elevation acute coronary syndromes completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome, Percutaneous Coronary Intervention | Phase 3 | Status: COMPLETED | Results posted: 2014-05-02